Search Results

Podcast

Novo Grilled by Senate, PhRMA’s IRA Win and BMS’ KarXT Awaits Approval

New revelations from the showdown between Novo Nordisk’s CEO and Bernie Sanders’ Senate health committee Tuesday; PhRMA’s legal victory in IRA case; the federal interest rate cut and anticipated approval for schizophrenia.

September 25, 2024

·

1 min read

·

Heather McKenzie

Photo of a judge's gavel, a balance and a stack of papers

Legal

Appeals Court Breathes New Life Into PhRMA’s Legal Challenge to IRA

A lawsuit filed by the Pharmaceutical Research and Manufacturers of America, which claims the Inflation Reduction Act’s Medicare Drug Price Negotiation Program is unconstitutional, now goes back to a lower Texas court.

September 23, 2024

·

2 min read

·

Tristan Manalac

Pictured: The inside of a federal courtroom/iStock

Policy

Texas Court Dismisses PhRMA IRA Lawsuit Against Biden Administration

On Monday, the Biden administration got an early victory in pharma’s legal challenge to the Inflation Reduction Act, with a Texas judge dismissing a complaint from the Pharmaceutical Research and Manufacturers of America.

February 13, 2024

·

2 min read

·

Tristan Manalac

Pictured: Illustration of office workers holding t

PhRMA, BIO Push Back Against Rare String of Setbacks

The two biopharmaceutical industry organizations entered Medicare price negotiations after the loss of several prominent members and executives.

January 23, 2024

·

4 min read

·

Neil Versel

Pictured: Sign above the entrance to a U.S. courthouse

Policy

PhRMA Loses Another Legal Battle as Court Sides with Arkansas Over Drug Discount Program

A lawsuit filed by the Pharmaceutical Research and Manufacturers of America failed to block an Arkansas law that empowers hospitals to use outside pharmacies to dispense discounted drugs.

March 14, 2024

·

2 min read

·

Tristan Manalac

Pictured: Boardroom overlooking a city/iStock, ism

Policy

PhRMA Names Gilead CEO O’Day as New Board Chair Following Loss of Members

With the departure of AbbVie and AstraZeneca from the trade group, Pharmaceutical Research and Manufacturers of America has named new members to its leadership including Gilead Sciences chief Daniel O’Day.

February 22, 2024

·

2 min read

·

Tristan Manalac

Pictured: Gavel with an assortment of tablets and

Policy

Industry Group Prepares Another Lawsuit Against Florida’s Drug Importation Plan

Following the FDA’s approval of the program, PhRMA is once again suing to block Florida from importing prescription drugs from Canada.

January 9, 2024

·

2 min read

·

Tristan Manalac

Business

C-Suite Shuffle: ReNAgade, Adaptimmune, Vittoria and More

Plus, last week Richard Gonzalez announced his retirement from AbbVie, PhRMA appointed Gilead’s O’Day to chair its board and Joseph Papa became president and CEO of Emergent.

February 28, 2024

·

5 min read

·

Neil Versel

Pictured: Law books and scales of justice on desk/

Policy

PhRMA Joins Merck, BMS in Latest Lawsuit Challenging IRA’s Drug Price Negotiations

On the heels of Merck’s and BMS’ lawsuits, the pharma industry’s lobbying group Wednesday filed a complaint in federal court asserting that the price-setting provisions in the Inflation Reduction Act are unconstitutional.

June 21, 2023

·

2 min read

·

Lisa Munger

Business

Eli Lilly and Company Chairman and CEO David Ricks Becomes PhRMA Board Chairman

WASHINGTON, Dec. 9, 2020 /PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) is pleased to announce that David Ricks, chairman and CEO of Eli Lilly and Company, has assumed the role of chairman of the PhRMA board of directors.

December 9, 2020

·

3 min read